Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: neuroprotective and anti-inflammatory activities

The treatment of Parkinson´s disease (PD) has benefited from significant advances resulting from the increasing research efforts focused on new therapeutics. However, the current treatments for PD are mostly symptomatic, alleviating disease symptoms without reversing or retarding disease progression...

Full description

Bibliographic Details
Main Author: Silva, Joana (author)
Other Authors: Alves, Celso (author), Pinteus, Susete (author), Susano, Patrícia (author), Simões, Marco (author), Guedes, Miguel (author), Martins, Alice (author), Rehfeldt, Stephanie (author), Gaspar, Helena (author), Goettert, Márcia Inês (author), Alfonso, Amparo (author), Pedrosa, Rui (author)
Format: article
Language:eng
Published: 2021
Subjects:
Online Access:http://hdl.handle.net/10400.8/5996
Country:Portugal
Oai:oai:iconline.ipleiria.pt:10400.8/5996